Bill Information > HB 2363
Search for another bill or initiative:
HB 2363 - 2015-16
Concerning pharmaceutical drug cost and utilization transparency.
Sponsors: Cody, Harris, Robinson, Van De Wege, Jinkins, Tharinger
Bill History

2016 REGULAR SESSION

IN THE HOUSE

Jan 8
Prefiled for introduction.
Jan 11
First reading, referred to Health Care & Wellness (Not Officially read and referred until adoption of Introduction report). (View Original Bill)
Jan 19
Public hearing in the House Committee on Health Care & Wellness at 8:00 AM. (Committee Materials)
Jan 27
Executive session scheduled, but no action was taken in the House Committee on Health Care & Wellness at 1:30 PM. (Committee Materials)
Jan 29
Executive session scheduled, but no action was taken in the House Committee on Health Care & Wellness at 10:00 AM. (Committee Materials)

2016 1ST SPECIAL SESSION

IN THE HOUSE

Mar 10
By resolution, reintroduced and retained in present status.
Available Documents
For a complete list of documents, go to Online Reports Text of a Legislative Document.
Fiscal Note
Amendments
Available Videos